FDA Announces New Advisory Committee To Address Risk Communication

Armen Hareyan's picture
Advertisement

U.S. Food and Drug Administration announced a new advisory committee designed to counsel the agency on how to strengthen the communication of risks and benefits of FDA-regulated products to the public.

Advertisement

The Risk Communication Advisory Committee will;

Advertisement